A Randomized Double-blind, Placebo-controlled Trial to E

Project: Research project

Project Details

Description

A Randomized Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability and Antiviral Activity of 12 Weeks??? Treatment with a New Antiviral Human CMV Drug
StatusFinished
Effective start/end date5/5/1012/20/12

Funding

  • AiCuris GmbH & Co. KG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.